Home › Myeloproliferative Neoplasms › NCT01137825
Registry of Older Patients With Cancer
RecruitingObservational study
Carolina Senior: UNC Registry for Older Cancer Patients
Who can join
Ages 65 and older · All sexes
Full eligibility criteria
DISEASE CHARACTERISTICS: * Patients must have an appointment at the North Carolina Cancer Hospital and agree to complete the Geriatric Assessment NOTE: Not all patients included in the registry will ultimately be diagnosed with cancer. Patients who complete a GA and are not diagnosed with cancer will remain in the database, but will be categorized into a separate group and will not have their medical records accessed. PATIENT CHARACTERISTICS: * Able to read and speak English PRIOR CONCURRENT THERAPY: * Not specified
About the study
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future.
PURPOSE: This research study is gathering information from older patients with cancer into a registry.
Sponsor: UNC Lineberger Comprehensive Cancer Center · Participants: 3,000 · Started: 2009-09
Contact the study team
- Kirsten A Nyrop, PhD · Phone: (919) 962-5139
Official record on ClinicalTrials.gov — NCT01137825
Locations in the U.S.
Conditions
- Myeloproliferative Neoplasms
- Leukemia
- Lymphoma
- Multiple Myeloma
- Plasma Cell Cancer
- Myelodysplastic Syndromes
- Accelerated Phase Myeloid Leukemia
- Acute Biphenotypic Leukemia
- Birth Defects
- Chronic Myeloid Leukemia
- Blast Crisis
- Chronic Myelomonocytic Leukemia
- Chronic-Phase Myeloid Leukemia
- Prolymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Chronic Lymphocytic Leukemia
- Hairy Cell Leukemia
- Large Granular Lymphocytic Leukemia
- Hodgkin Lymphoma
- Anaplastic Large-Cell Lymphoma
- Immunoblastic Lymphadenopathy
- Cutaneous T-Cell Lymphoma
- Mycosis Fungoides
- Sezary Syndrome
- Extranodal NK-T-Cell Lymphoma
- Waldenstrom Macroglobulinemia
- Marginal Zone Lymphoma
- Burkitt Lymphoma
- Diffuse Large B-Cell Lymphoma
- Non-Hodgkin Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Myelofibrosis
- Essential Thrombocythemia
- Polycythemia Vera
- Immunoglobulin Light-chain Amyloidosis
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.